Amylex is a leading-edge biotechnology firm dedicated in delivering revolutionary therapeutics and diagnostics tackling some of the world's most devastating and prevalent diseases. Its pioneering science, developed over a decade of research, may serve as the key in providing medical solutions that will benefit millions of people around the world.